Literature DB >> 24907698

Behavioral and EEG changes in male 5xFAD mice.

F Schneider1, K Baldauf2, W Wetzel3, K G Reymann4.   

Abstract

Transgenic animal models of Alzheimer's disease (AD) are widely used to investigate mechanisms of pathophysiology and cognitive dysfunctions. A model with a very early development of parenchymal plaque load at the age of 2months is the 5xFAD mouse (Tg6799, Oakley et al. 2006). These 5xFAD mice over-express both human amyloid precursor protein (APP) and human presenilin 1 (PS1). Mice from this line have a high APP expression correlating with a high burden and an accelerated accumulation of the 42 amino acid species of amyloid-β (Aβ). The aim of this study was the behavioral and functional investigations of 5xFAD males because in most studies females of this strain were characterized. In comparison to literature of transgenic 5xFAD females, transgenic 5xFAD males showed decreased anxiety in the elevated plus maze, reduced locomotion and exploration in the open field and disturbances in learning performance in the Morris water maze starting at 9months of age. Electroencephalogram (EEG) recordings on 6month old transgenic mice revealed a decrease of delta, theta, alpha, beta and gamma frequency bands whereas the subdelta frequency was increased. EEG recordings during sleep showed a reduction of rapid eye movement sleep in relation to the amount of total sleep. Thus, 5xFAD males develop early functional disturbances and subsequently behavioral deficits and therefore they are a good mouse model for studying Alzheimer's disease.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5xFAD mice; Cognitive deficits; EEG; Non-cognitive impairments; Sleep recording

Mesh:

Substances:

Year:  2014        PMID: 24907698     DOI: 10.1016/j.physbeh.2014.05.041

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  45 in total

1.  Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist.

Authors:  Pooneh Memar Ardestani; Andrew K Evans; Bitna Yi; Tiffany Nguyen; Laurence Coutellier; Mehrdad Shamloo
Journal:  Neuropharmacology       Date:  2017-01-13       Impact factor: 5.250

2.  Dysfunction of GABAergic neurons in the parafacial zone mediates sleep disturbances in a streptozotocin-induced rat model of sporadic Alzheimer's disease.

Authors:  Jin-Zhi Song; Su-Ying Cui; Xiang-Yu Cui; Xiao Hu; Yu-Nu Ma; Hui Ding; Hui Ye; Yong-He Zhang
Journal:  Metab Brain Dis       Date:  2017-10-28       Impact factor: 3.584

Review 3.  Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors.

Authors:  Chanung Wang; David M Holtzman
Journal:  Neuropsychopharmacology       Date:  2019-08-13       Impact factor: 7.853

4.  Sleep Disturbance: An Early Sign of Alzheimer's Disease.

Authors:  Chao He; Zhian Hu; Chenggang Jiang
Journal:  Neurosci Bull       Date:  2019-12-05       Impact factor: 5.203

5.  Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease.

Authors:  Natalia Mast; Aicha Saadane; Ana Valencia-Olvera; James Constans; Erin Maxfield; Hiroyuki Arakawa; Young Li; Gary Landreth; Irina A Pikuleva
Journal:  Neuropharmacology       Date:  2017-06-24       Impact factor: 5.250

6.  Impaired Hippocampal-Cortical Interactions during Sleep in a Mouse Model of Alzheimer's Disease.

Authors:  Sarah D Benthem; Ivan Skelin; Shawn C Moseley; Alina C Stimmell; Jessica R Dixon; Andreza S Melilli; Leonardo Molina; Bruce L McNaughton; Aaron A Wilber
Journal:  Curr Biol       Date:  2020-05-28       Impact factor: 10.834

7.  Pregnane X Receptor Deletion Modifies Recognition Memory and Electroencephalographic Activity.

Authors:  Badreddine Boussadia; Laila Lakhal; Laurence Payrastre; Chaitali Ghosh; Jean-Marc Pascussi; Giuseppe Gangarossa; Nicola Marchi
Journal:  Neuroscience       Date:  2017-07-23       Impact factor: 3.590

Review 8.  Impact of sleep disturbances on neurodegeneration: Insight from studies in animal models.

Authors:  Jessica E Owen; Sigrid C Veasey
Journal:  Neurobiol Dis       Date:  2020-02-19       Impact factor: 5.996

9.  Sleep and EEG Power Spectral Analysis in Three Transgenic Mouse Models of Alzheimer's Disease: APP/PS1, 3xTgAD, and Tg2576.

Authors:  Brianne A Kent; Stephen M Strittmatter; Haakon B Nygaard
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 10.  Anxiety and Alzheimer's disease: Behavioral analysis and neural basis in rodent models of Alzheimer's-related neuropathology.

Authors:  Nathan S Pentkowski; Kimberly K Rogge-Obando; Tia N Donaldson; Samuel J Bouquin; Benjamin J Clark
Journal:  Neurosci Biobehav Rev       Date:  2021-05-09       Impact factor: 9.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.